Doctor Explains NEW Retatrutide Benefits & Findings (not what you think)
Dr. Jones, DC — Doctor Explains NEW Retatrutide Benefits & Findings (not what you think)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=-eRdb728ypA
What this video covers
But the relief doesn’t seem to be waiting for the scale. And if that’s true, it changes when you expect to feel better and whether you get to keep it. Jones DC and I coached thousands of patients through GLP1 protocols. This one’s personal for me because I was 300 lb by the age of 16.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Jones DC and I coached thousands of patients through GLP1 protocols.
- So, that phase 3 trial data ran 445 people with knee arthritis and a BMI over 27 for 28 weeks.
- attention, expectation, and the simple fact that people usually sign up for a study when their pain is at its worst.
- Now, when sagglutide was tested head-on in knee arthritis in a peer-reviewed trial in the New England Journal, the pain relief was large and that’s a drug that we know causes lean mass loss along the way.
- Inflammation driving insulin resistance, but insulin resistance driving more inflammation.
- Not in a study, but in actual patients, right, the clinical setting.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.